Veracyte Inc is a company in the U.S. stock market and it is a holding in 43 U.S.-traded ETFs. VCYT has around 6.4M shares in the U.S. ETF market. The largest ETF holder of VCYT is the ARK Innovation ETF (ARKK), with approximately 1.42M shares. Investors may also find of interest that the ETF with the largest allocation to VCYT stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 3.99%. On average, U.S. ETFs allocate 0.44% of VCYT to their portfolios.
Additionally, VCYT is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VCYT as a holding is the Vanguard Total Stock Market ETF (VTI), with a return of 8.18%.